Brain MR imaging of chronic alcoholism;Imagerie par résonance magnétique (IRM) des complications encéphaliques de l'alcoolisme

Journal de Radiologie

Volumn 84, Issue 4 I, 2003, Pages 369-379

  Vargas, M I ^a   Lenz, V ^a   Bin, J F ^a   Bogorin, A ^a   Eid, M Abu ^a   Jacques, C ^a   Marin, H ^a   Kindo, S ^a   Zollner G ^a   Dietemann, J L ^a  

^a HÔPITAL DE HAUTEPIERRE   (France)

Author keywords

Alcoholism; Brain; Central pontine myelinolysis; Cerebellar atrophy; Hepatic encephalopathy; Marchiafava Bignami disease; MR imaging; MRI; Wernicke Korsakoff encephalopathy

Indexed keywords

DISULFIRAM; GADOLINIUM;

ALCOHOLISM; BRAIN; BRAIN ISCHEMIA; CENTRAL PONTINE MYELINOLYSIS; CEREBELLUM ATROPHY; CEREBROVASCULAR DISEASE; DIAGNOSTIC IMAGING; DRUG INTOXICATION; HEPATIC ENCEPHALOPATHY; HUMAN; IMAGE ANALYSIS; IMAGING SYSTEM; KORSAKOFF PSYCHOSIS; MARCHIAFAVA BIGNAMI DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; WERNICKE ENCEPHALOPATHY;

ALCOHOL-INDUCED DISORDERS, NERVOUS SYSTEM; BRAIN; BRAIN DISEASES; COMORBIDITY; HUMANS; MAGNETIC RESONANCE IMAGING; SENSITIVITY AND SPECIFICITY; SMOKING;

EID: 0038539554     PISSN: 02210363     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (100)

1. Wernicke C. Lehrbuch der Gehirnkrankheiten für Aerzte und Studierende. Vol 2. Fischer, édit., Berlin, 1881.
2. Bergui M, Bradac GB, Zhong JJ, Barbero PA, Durelli L. Diffusion-weighted MR in reversible Wernick encephalopathy. Neuroradiology 2001;43:369-72.
3. Gardian G, Voros E, Jardanhazy T, Ungurean A, Vecsei L. Wernicke's encephalopathy induced by hypermesis gravidarum. Acta Neurol Scand 1999;99: 196-8.
4. Ohkoshi N, Ishii A, Shoji S. Wernicke's encephalopathy induced by peremesis gravidarum, associated with bilateral caudate lesions on computed tomography and magnetic resonance imaging. Eur Neurol 1994;34:177-80.
5. 10, 1991, 13p.
6. Oppdenakker G, Gelin G, De Surgeloose D, Palmers Y. Wernicke encephalopathy: MR findings in two patients. Eur Radiol 1999;9:1620-4.
7. Adams JH, Corsellis JAN, Duchen LW. Greenfield's neuropathology. Fourth Edition. Edward Arnold, édit., London, 1984.
8. Davis RL, Robertson DM. Textbook of neuropathology. Williams & Wilkins, édit., Baltimore, London, 1985.
9. Antunez E, Estruch R, Cardenal C, Nicolas JM, Fernandez-Sola J, UrbanoMarquez A. Usefulness of CT and MR imaging in the diagnosis of acute Wernicke's encephalopathy. AJR 1998;171: 1131-7.
10. Bae SJ, Lee K, Lee JH, Choi CG, Suh DC. Wernicke's encephalopathy: atypical manifestation at MR imaging. AJNR 2001;22:1480-2.
11. Doraiswamy PM, Massey EW, Enright K, Palese VJ, Lamonica D, Boyko O. Wernicke-Korsakoff syndrome caused by psychogenic food refusal: MR findings AJNR 1994;15:594-6.
12. Gallucci M, Bozzao A, Splendiani A, Masciocchi C, Passariello R. Wernicke encephalopathy: MR findings in five patients. AJR 1990;155:1309-14.
13. D'Aprile P, Gentile MA, Carella A. Enhanced MR in the acute phase of Wernicke encephalopathy. AJR 1994;15: 591-3.
14. Harter SB, Nokes SR. Gadolinium-enhanced MR findings in a pediatric case of Wernicke encephalopathy. AJNR 1995;16:700-2.
15. Shogry ME, Curnes JT. Mamillary body enhancement on MR as the only sign of acute Wernicke encephalopathy. AJNR 1994;15:172-4
16. Schroth G, Wichmann W, Valavanis A. Blood-brain-barrier disruption in acute Wernicke encephalopathy: MR findings. J Comput Assist Tomogr 1991; 15:1059-61.
17. Murata T, Fujito T, Kimura H, Omori M, Itoh H, Wada Y. Serial MRI and 1H-MRS of Wernicke's encephalopathy: report of a case with remarkable cerebellar lesions on MRI. Psychiatry Res 2001;108: 49-55.
18. Yamashita M, Yamamoto T. Wernicke encephalopathy with symmetric pericentral involvement: MR findings. J Comput Assist Tomogr 1995;19:306-8.
19. Oka M, Terae S, Kobayashi R, et al. Diffusion-weighted MR findings in a reversible case of acute Wernicke encephalopathy. Acta Neurol Scand 2001; 104:178-81.
20. Burdette JH, Elster AD, Ricci PE. Acute cerebral infarction: quantification o spin-density and T2 shine-through phenomena on diffusion-weighted MR images. Radiology 1999;212:333-9.
21. Dietemann JL, Jacques C, Schneider F, et al. L'encéphalopathie postérieure réversible Feuillets de Radiologie 2001; 41:397-405.
22. Park SH, Kim M, Na DL, Jeon BS. Magnetic resonance reflects the pathological evolution of Wernicke encephalopathy. J Neuroimaging 2001;11:406-11.
23. Lenz V, Vargas MI, Bin JF, Bogorin A, et al. Apport de l'IRM dans l'exploration de l'encéphalopathie de Gayet-Wernicke. J Neuroradiol, 2002;29:153-60.
24. Okino S, Sakajiri K, Fukushima K, Ide Y, Takamori M. A case of Wernicke-Korsakoff syndrome caused by gastrojejumostmy - specific findings of MRI and SPECT. Rinsho Shinkeigaku 1993;33: 530-4.
25. Chick JD, Smith MA, Engleman HM, et al. Magnetic resonance imaging of the brain in alcoholics: cerebral atrophy, lifetime alcohol consumption, and cognitive deficits Alcohol Clin Exp Res 1989;13:512-8.
26. Emsley R, Smith R, Roberts M, Kapnias S, Pierters H, Maritz S. Magnetic resonance imaging in alcoholic Korsakoff's syndrome: evidence for an association with alcoholic dementia. Alcohol Clin Exp Res 1996;31:479-86.
27. Jernigan T, Butters N, Di Traglia G, et al. Reduced cerebral grey matter observed in alcoholics using magnetic resonance imaging. Alcohol Clin Exp Res 1991;15:418-27.
28. Agartz I, Momenan R, Rawlings R, Kerich MJ, Hommer DW. Hippocampal volume in patients with alcohol dependence. Arch Gen Psychiatry 1999;56: 356-63.
29. Laasko MP, Vaurio O, Savolainen L, et al. A volumetric MRI study of the hippocampus in type 1 and 2. Behav Brain Res 2000;109:177-86.
30. Hommer D, Momenan R, Rawlings R, et al. Decreased corpus callosum size among alcoholic women. Arch Neurol 1996;53:359-63.
31. Pfefferbaum A, Lim KO, Desmond JE, Sullivan EV. Thinning of the corpus callosum in older alcoholic men: a magnetic resonance imaging study. Alcohol Clin Exp Res 1996;20:752-7.
32. Oishi M, Mochizuki Y, Shikata E. Corpus callosum atrophy and cerebral blood flow in chronic alcoholics. J Neurol Sci 1999;162:51-5.
33. Sullivan EV, Mathalon DH, Lim KO, Marsh L, Pfefferbaum A. Patterns of regional cortical dysmorphology distinguishing schizophrenia and chronic alcoholsm. Biol Psychiatry 1998;43: 118-31.
34. Liu RS, Lemieux L, Shorvon SD, Sisodiya SM, Duncan JS. Association between brain size and abstinence from alcohol. Lancet 2000;355:1969-70.
35. Pfefferbaum A, Sullivan EV, Mathalon DH, Shear PK, Rosenbloom MJ, Lim KO. Longitudinal changes in magnetic resonance imaging brain volumes in abstinent and relapsed alcoholics. Alcohol Clin Exp Res 1995;19:177-91.
36. Shear PK, Jernigan TL, Butters N. Volumetric magnetic resonance imaging quantification of longitudinal brain changes in abstinent alcoholics. Alcohol Clin Exp Res 1994;18:172-6.
37. Jagannathan NR, Desai NG, Raghunathan P. Brain metabolic changes in alcoholism: an in vivo proton magnetic resonance spectroscopy (MRS) study Magn Reson Imaging 1996;14:553-7.
38. Seitz D, Widmann U, Seeger U, et al. Localized proton magnetic resonance spectroscopy of the cerebellum in detoxifying alcoholics. Alcohol Clin Exp Res 1999;23:158-63.
39. Bendszus M, Weijers HG, Wiesbeck, et al. Sequential MR imaging and proton MR spectroscopy in patients who underwent recent detoxification for chronic alcoholism: correlation with clinical and neuropsychological data. AJNR 2001; 22:1926-32.
40. Bracard S, Claude D, Vespignani H, et al. Computerized tomography and MR in Marchiafava-Bignami disease. J Neuroradiol 1986;13:87-94.
41. Marchiafava E, Bignami A. Sogra un alterazione del corpo calloso osservata in soggeti alcoolisti. Rivista di Pathologia Nervosa e Mentale 1903;8:544-9.
42. Izquierdo G, Ouesada MA, Chacon J, Martel J. Neuroradiologic abdnormalities in Machiafava-Bignami disease of benign evolution. Eur J Radio 1992;15: 71-4.
43. Shiota JY, Nakano I, Kawamura M, Hiravama K. An autopsy case of Marchiafava-Bignami disease with peculiar chronological CT changes in the corpus callosum: neuropathological correlations. J Neurol Sci 1996;136:90-3.
44. Caparros-Lefébvre D, Pruvo JP, Josien E, Pertuzon B, Clarisse J, Petit H. Marchiava-Bignami disease: use of contraste media in CT and MRI. Neuroradiology 1994;36:509-11.
45. Kollar J, Peter M, Fulesdi B, Sikula J. Is every sharply defined, symmetrical, necrotic-demyelinating lesion in the corpus callosum an actual manifestation of Marchiafava-Bignami disease? Eur J Radiol 2001;39:151-4.
46. Navarro JF, Noriega S. Marchiafava-Bignami disease. Rev Neurol 1999;28: 519-23.
47. Yamamoto T, Ashikaga R, Araki Y, Nishimura Y. A case of Marchiafava-Bignami disease: MRI findings on spinecho and fluid attenuated inversion recovery (FLAIR) images. Eur J Radiol 2000;34:141-3.
48. Inagaki T, Saito K. A case of Machiafava-Bignami disease demonstrated by MR diffusion-weighted image. No To Shinkei 2000;52:633-7.
49. Ruiz-Martinez J, Martinez Perez-Balsa A, Ruibal M, Urtasun M, Villanua J, Marti Masso JF. Marchiafava-Bignami disease with widespread extracallosal lesions and favourable course. Neuroradiology 1999;41:40-3.
50. Gass A, Birtsch G, Olster M, Schwartz A, Hennerici MG. Marchiafava-Bignami: reversibility of neuroimaging abnormality. J Comput Assit Tomogr 1998;22: 503-4.
51. Helenius J, Tatlisumak T, Soinne L, Valanne L, Kaste M. Marchiafava-Bignami disease: two cases with favourable outcome. Eur J Neurol 2001;269-72.
52. Adams RD, Victor M, Mancall EL. Central pontine myelinolysis: a hitherto undescribed disease occuring in alcoholic and malnourished patients. Arch Neurol Psychiatry 1959;8:154-72.
53. Laubenberger J, Schneider B, Ansorge O, et al. Central pontoine myelinolysis: clinical presentation and radiologic findings. Eur Radiol 1996;6:177-83.
54. Miller GM, Baker JL Jr, Okazaki H, Whisnant JP. Central pontine myelinolysis and its imitators: MR findings. Radiology 1988;168:795-802.
55. Thompson AJ, Brown MM, Swash M, Thakkar C, Scholtz C. Autopsy validation of MRI in central pontine myelinolysis. Neuroradiology 1988;30:175-7.
56. Bourgouin PM, Chalk C, Richardson J, Duang H, Vezina JL. Subcortical white matter lesions in osmotic demyelination syndrome. AJNR 1995;16:1495-7.
57. Koci TM, Chiang F, Chow P, et al. Thalamic extrapontine lesions in central pontine myelinolysis. AJNR 1990;11: 1229-33.
58. Gocht A, Colmant HJ. Central pontine and extrapontine myelinolysis: a report of 58 cases. Clin Neuropathol 1987;6: 262-70.
59. Hadfield MG, Kuba WS. Extrapontine mylinolysis of the basal ganglia without central pontine myelinilysis. Clin Neuropathol 1996;15:96-100.
60. Susa S, Daimon M, Morita Y, et al. Acute intermittent porphyria with central pontine myelinolysis and cortical laminar necrosis. Neuroradiology 1999; 41:835-9.
61. Shoji M, Kimura T, Ota K, et al. Cortical laminar necrosis and central pontine myelinolysis in a patient with Sheehan syndrome and severe hyponatremia. Inter Med 1996;35:427-31.
62. Waragai M, Satoh T. Serial MRI of extrpontine myelinolysis of the basal ganglia: a case report. J Neurol Sci 1998; 161:173-5.
63. Brunberg JA, Kanal E, Hirsch W, Van Thiel DH. Chronic acquired hepatic failure: MR imaging of the brain at 1.5 T. AJNR 1991;12:909-14.
64. Inoue E, Hori S, Narumi Y, et al. Portalsystemic encephalopathy: presence of basal ganglia lesions with high signal intensity on MR images. Radiology 1991;179:551-5.
65. Maeda H, Sato M, Yoshikawa A, et al. Brain MR imaging in patients with hepatic cirrhosis: relationship between high intensity signal in basal ganglia on T1weighted images and elemental concentrations in brain. Neuroradiology 1997; 39:456-60.
66. Morgan MY. Cerebral magnetic resonance imaging in patients with chronic liver disease. Metab Brain 1998;13: 273-90.
67. Watanabe A. Cerebral changes in hepatic encephalopathy. J Gastroenterol Hepatol 1998;13:752-60.
68. Uchino A, Hasuo K, Matsumoto S, Matsuda K. Cerebral magnetic resonance imaging of liver cirrhosis patients. Clin Imaging 1994;18:123-30.
69. Genovese E, Maghnie M, Maggiore G, et al. MR imaging of CNS involvement in children affected by chronic liver disease. AJNR 2000;21:845-51.
70. Thuluvath PJ, Edwin D, Yue NC, de Villiers C, Hochman S, Klein A. Increased signals seen in globus pallidus in T1-weighted magnetic resonance imaging in cirrhotics are not suggestive of chronic hepatic encephalopathy. Hepatology 1995;21:440-2.
71. Butterworth RF, Spahr L, Fontaine S, Layrargues GP. Manganese toxicity, dopaminergic dysfunction an hepatic encephalopathy. Metab Brain Dis 1995;10:259-67.
72. Dietemann JL, Reimund JM, Diniz RLFC, et al. High signal in the adenohypophysis on T1-weighted images presumably due to manganese deposits in patients on long-term parenteral nutrition. Neuroradiology 1998;40:793-6.
73. Pujol A, Pujol J, Graus F, et al. Hyperintense globus pallidus on T1-weighted MRI in cirrhotic patients is associated with severity of liver failure. Neurology 1993;43:65-9.
74. 1H spectroscopy of brain metabolites in hepatic encephalopathy: time-course of renormalization after liver transplantation. Radiology 2000;216:683-91.
75. Krieger S, Jauss M, Jansen O, et al. MRI findings in chronic hepatic encephalopathy depend on portosystemic shunt: results of a controlled prospective clinical investigation. J Hepatol 1997;27: 121-6.
76. Matsumoto S, Mori H, Yoshioka K, Kiyosue H, Komatsu E. Effects of portal-systemic shunt embolization on the basal ganglia: MRI. Neuroradiology 1997;39: 326-8.
77. Arnold SM, Els R, Spreer J, Schumacher M. Acute hepatic encephalopathy with diffuse cortical lesions. Neuroradiology 2001;43:551-4.
78. Cavanagh JB, Holton JL, Nolan CC. Selective damage to the cerebellar vermis in chronic alcoholism: a contribution from neurotoxicology to an old problem of selective vulnerability. Neuropathol Appl Neurobiol 1997;23:355-63.
79. Manto MU, Jacquy J. Alcohol toxicity in the cerebellum: clinical aspects In: Ther cerebellum and its disorders. MU Manto, Pandolof M, eds. Cambridge University Press, édit., Cambridge, 2002.
80. Nicolas JM, Fernandez-Sola J, Robert J, et al. High ethanol intake and malnutrition in alcoholic cerebellar shrinkage. QJM 2000;93:449-56.
81. Sowell ER, Jernigan TL, Mattson SN, Riley EP, Sobel DF, Jones KL. Abnormal develpment of the cerebellar vermis in children prenatally exposed to alcohol: size reduction in lobules 1-V. Alcohol Clin Exp Res 1996;20:31-4
82. Mattson SN, Riley EP, Sowel ER, Jernigan TL, Sobel DF, Jones KL. A decrease in the size of the basal ganglia in children with fetal alcohol syndrome. Alcohol Clin Exp Res 1996;20:1088-93.
83. Juvela S, Hillbom M, Palomaki H. Risk factors for spontaneous intracrebral hemorrage. Stroke 1995;26:1558-64.
84. Juvela S. Alcohol consumption as a risk factor for poor outcome after aneurysmal subarachnoid haemorrhage. BJM 1992;304:1663-7.
85. Merlicco G, Pierangeli E, Di Padova PL. Chronic subdural hematomas in adults: prognostic factors. Analysis of 70 cases. Neurosurg Rev 1995;18:247-51.
86. 10, 1998.
87. Gallucci M, Amicarelli I, Rossi A, et al. MR imaging of withe matter lesions in uncomplicated chronic alcoholism. J Comput Assist Tomogr 1989;13:395-8.
88. Hayakawa K, Kumagai H, Suzuki Y, et al. MR imaging of chronic alcoholism. Acta Radiol 1992;33:201-6.
89. Chen JC, Schneiderman JF, Wortzman G. Methanol poisoning: bilateral putaminal and cerebellar cortical lesions on CT and MR. J Comput Assist Tomogr 1991; 15:522-4.
90. Deniz S, Oppenheim C, Lehericy S, et al. Diffusion-weighted magnetic resonance imaging in a case of methanol intoxication. Neurotoxicology 2000;21:405-8.
91. Gaul HP, Wallace CJ, Auer R, Fong TC. MR findings in methanol intoxication. AJNR 1995;16:1783-6.
92. Kuteifan K, Oesterlé H, Tajahmady T, Gutbub AM, Laplatte G. Necrosis and haemorrhage of the putamen in methanol poisonin schown on MRI. Neuroradiology 1998;40:158-60.
93. Rubinstein D, Escott E, Kelly JP. Methanol intoxication with putaminal and white matter necrosis MR and CT findings. AJNR 1995;16:1492-4.
94. Anderson CA, Rubinstein D, Filley CM, Stears JC. MR enhancing brain lesions in methanol intoxication. J Comput Assist Tomogr 1997;21:834-6.
95. Dubas F, Verny C. Encéphalopathies métaboliques et toxiques. Elsevier, édit. Éditions Techniques. Encycl Méd Chir, Neurologie, 17-055-A-70, 1996, 9p.
96. Onder F, Ilker S, Kansu T, Tatar T, Kural G. Acute blindness and putaminal necrosis in methano intoxication. Int Ophtlamol 1998-99;22:81-4.
97. Boukriche Y, Weisser I, Aubert P, Masson C. MRI findings in a case of late onset disulfiram-induced neurotoxicity. J Neurol 2000;247:714-5.
98. Laplane D, Attal N, Sauron B, de Billy A, Dubois B. Lesions of basal ganglia due to disulfiram neurotoxicity. J Neurol Neurosurg Psychiatry 1992;55:925-9.
99. Riley D. Pallidal and putaminal lesions resulting from disulfiram intoxication. Mov Disord 1991;6:166-70.
100. Thannberger P, Wilhelm JM, Saraceni O, Derragui A, Dietemann JL, Kieffer P. Intoxication aiguë au disulfirame avec séquelles neurologiques graves et présentation psychiatrique déficitaire trompeuse. Rev Neurol 2000;156:780-2.